INVEST PharmaTech
MedCity News inaugural virtual INVEST PharmaTech will feature conversations around AI, drug discovery, virtual clinical trials, and more.
MedCity News inaugural virtual INVEST PharmaTech will feature conversations around AI, drug discovery, virtual clinical trials, and more.
Biocom California invites you to mix and mingle LIVE and IN-PERSON with your fellow CFOs within the life sciences industry. Enjoy hosted hors d'oeuvres and cocktails during this informal networking reception. These receptions are designed for CFOs of life science companies to network with one another on a peer‐to‐peer level and provides a venue for...
We are very excited to announce our outdoor Summer Biotech Community Event at the Tech Square Courtyard, Kendall Square, 400 Technology Square, Cambridge, MA, 02139 All the biotech tenants at 100-700 Technology Square and other companies in the Cambridge vicinity will be invited to attend this event. The event is being promoted as a special...
On August 11-14, we will be meeting virtually to hear the latest developments from the leading experts. This conference will bring together the leading experts in rejuvenation biotechnology and investment in order to foster scientific and business collaborations to develop rejuvenation therapies that target the root causes of aging. In addition to bringing together the...
After a two-year hiatus, the Biocom California Purchasing Group is excited to announce the return of our annual Bay Area Open House and Supplier Showcase, held this year at the Domenico Winery in San Carlos. Join us for wine sampling and delectable appetizers in this private event and lounge space where the atmosphere will transport...
For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocess R&D, scale-up, quality and analytics. As we navigate the new realities of conferences and gatherings, you can count on CHI’s commitment to deliver quality content and facilitated networking opportunities to...
Held concurrently with CLS' Board of Directors meeting, the annual An Evening with Thought Leaders held at Balboa Bay Resort, provides an opportunity to connect with industry visionaries and key opinion leaders on all facets of the life sciences. With over 100 life sciences professionals in attendance, 60% holding director-level titles or higher, don’t miss...
Aug 17, 6:00 PM PDT – Aug 20, 12:00 PM PDT Online on Zoom & In-person in San Francisco Healthcare is going through rapid change. Physician Innovators and others are driving some of this through their innovations. This conference is a curation of the best ideas, experts, startups and learning. Come experience the cutting edge...
Advancing Diagnostics Together We are proud to host Cambridge Healthtech Institute's Fourteenth Annual Next Generation Dx Summit which will take place in-person at the Grand Hyatt Washington, D.C. on August 22-24. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology...
Session 1 of a 3-part webinar series focusing on DEI strategies that are making an impact for companies across the country. Not your typical workshop. Candace Nortey, Managing Director of Diversity, Equity, and Inclusion Services by Slone Partners, hosts an engaging and impactful three-part webinar series focusing on DEI strategies that are making an impact...
Hosted by Sikich and Coupa, this webinar will discuss how an innovative biopharmaceutical company, Werewolf Therapeutics Life Sciences, successfully transformed its spend management processes by driving efficiencies, increasing savings, and implementing efficient and compliant systems on a scalable foundation for growth.
Over the last 12 months, the integrins industry has witnessed promising data and clinical updates: 7 Hills Pharma’s new study demonstrated integrin activation can bring the heat to cold melanoma tumors and received the FDA’s Fast Track and Orphan Drug designation Caladrius Biosciences and Cend Therapeutics presented their alpha-v integrins PhIb/IIa trial data in pancreatic, colorectal and appendiceal...